Early detection saves lives · Disease control and eradication
One platform, many algorithms, many products — deployed across national screening programmes, hospital diagnostics, and joint medical research, so every clinician can detect earlier, decide faster, and achieve the scale.
Algorithms live on the platform. They combine into disease-specific products, which bundle into deployable clinical solutions — commercialised through three distinct business lines.
Deep Learning, Machine Learning, GenAI models trained on large-scale medical imaging and clinical data — X-rays, CT, mammography and more. Core building blocks include Rises CDS and Rises GenAI Guru.
Disease-focused field-validated products e.g. Rises ThorDx™ for AI based detection on CXR for Pulmonary Conditions, Rises MammoDx™ for breast cancer 2D mammography, and more.
Products bundled for an use case — population screening, women’s health from screening to survivorship, and occupational & climate-linked health risk.
Each line has its own customer, its own commercial model, and its own route to putting rises.AI to work.
"Early detection saves lives." · "Disease control and eradication."
We build and supply the technology; operations are run by Government, social-impact organisations, NGOs or diagnostic partners — funded through government programmes, CSR and corporate-support pools.
Hospital and diagnostic-chain market
Enterprise-grade AI, co-created with collaborating institutes and tailored for workflows and clinical use case, delivered on a B2B or medical-service commercial model.
Are you a hospital or diagnostic chain open to co-creation? Let's talk →
With medical institutions, the NHS and healthcare researchers
Think drug-discovery R&D — the resulting product can generate revenue for more than a decade or more.
Medical institute interested in a joint grant or study? Reach out →
Each product combines algorithms from the rises.AI platform around a specific disease or clinical workflow — spanning detection, treatment-response assessment and prognostics, as part of our Clinical Decision Support solution and Rises GenAI Guru.
A medical AI assistant providing three-layered support: automated disease detection on first visit, disease-progression analytics on follow-up, and prognostic, predictive patient profiling — with fully customisable automated reporting.
RAG- and LLM-based conversational AI plus fine-tuned small language models, built for healthcare — supporting patient-centric clinical decisions, treatment tracking and prognostic assessment across medical imaging and multi-modal data.
AI for pulmonary conditions on chest X-ray — TB plus 20+ abnormalities (pneumonia, effusion, nodules, emphysema, fibrosis, silicosis and more). Edge-capable on a Mobile Medical Unit, syncing to cloud when connected.
Breast-cancer-first women's health AI — detection and classification with BI-RADS scoring across 2D mammography, 3D tomosynthesis, CECT, ultrasound and MRI, from screening through treatment-response and onco lifecycle management.
From mobile screening in the field through to hospital-grade diagnosis.
From mobile screening to hospital connect
Screening : breast-cancer-first women's health AI — detection and classification with BI-RADS scoring on 2D mammography, powered by Rises MammoDx. Suspect cases are referred to hospital for further investigation and treatment.
Screening for four primary, climate-linked conditions
Detection tech with fast turnaround
Co-creation framework for hospital departments and diagnostic focus areas.
We're actively looking for hospitals and diagnostic chains ready to co-create, medical institutes ready to pursue joint grants, and investors who want in on a de-risked, multi-line healthcare AI model.
Co-create a workflow-specific solution with us — from breast oncology to neurosurgery assist to A&E triage. You're a co-builder, not just a customer, with a hybrid payment model.
Propose a co-creationJoint research that ships a product — clinical validation, large datasets, and a concept-to-productisation pipeline, with joint IP structures where appropriate.
Discuss a joint grantThree strong revenue lines, institutional payers and a validated proof point — innovation-driven and focused, on the rises.AI platform-based SaaS B2B and B2G model. Ask us for the revenue model and investor storyboard.
Request the investor deckNITI Aayog, ICMR, TCS NASSCOM, the Stop TB Partnership, and 25+ more moments from our journey so far — now with the full story, on one page.
Rises Analytics Solutions Pvt Ltd was founded with the urge to conquer goals that make a meaningful impact on people's lives through the application of innovative technologies — bringing high-tech diagnostics within reach of clinicians and patients everywhere. Incubated at the AIC-LMCP Foundation under the Atal Innovation Mission (NITI Aayog), with further support from IITB SINE and T-Hub Hyderabad.
Whether you're a government health programme, a hospital ready to co-create, a medical institute pursuing a joint grant, or an investor — we'd like to hear from you.
Government health departments, CSR teams, hospitals, diagnostic chains, OEMs, medical-service providers, medical institutes and investors — one inbox, fast response.
Email: hello@rises.io
hello@rises.ioMessage us directly on WhatsApp for a quick conversation — co-creation proposals, grant discussions or investor queries all welcome.
WhatsApp: +91 98225 74086
Chat on WhatsApp